(Q61909314)
Statements
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment (Single-Center, Open-label, Parallel-Group, Single-Dose Study) (English)
0 references
June 2015
0 references
December 2017
0 references
32
0 references
18 year
0 references
75 year
0 references